Microbiome metabolomics reveals new drivers of human liver steatosis.

Delzenne, Nathalie;Bindels, Laure
(2018) Nature Medicine — Vol. 24, n° 7, p. 906-907 (2018)

Files

2018_Delzenne_Nat_Med.pdf
  • Restricted Access
  • Adobe PDF
  • 2.44 MB
Request a copy

Details

Authors
Abstract
An integrative multiomics approach in nondiabetic obese women identifies phenylacetate as a microbial metabolite contributing to the accumulation of lipids in the liver and hence to nonalcoholic steatohepatitis.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Delzenne, N., & Bindels, L. (2018). Microbiome metabolomics reveals new drivers of human liver steatosis. Nature Medicine, 24(7), 906-907. https://doi.org/10.1038/s41591-018-0126-3 (Original work published 2018)